Literature DB >> 3813519

Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.

C R Horsburgh, D L Cohn, R B Roberts, H Masur, R A Miller, A Y Tsang, M D Iseman.   

Abstract

Susceptibility testing and serotyping were performed on 57 isolates of Mycobacterium avium-M. intracellulare from patients with acquired immunodeficiency syndrome (AIDS) and 75 isolates from patients without AIDS. Susceptibility patterns and serotypes of AIDS isolates were significantly different from those of non-AIDS isolates. These results may partially explain the poor therapeutic response of M. avium-M. intracellulare infections in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3813519      PMCID: PMC180630          DOI: 10.1128/AAC.30.6.955

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Treatment of infections in patients with the acquired immunodeficiency syndrome.

Authors:  D Armstrong; J W Gold; J Dryjanski; E Whimbey; B Polsky; C Hawkins; A E Brown; E Bernard; T E Kiehn
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

Review 2.  Immunopathogenesis of the acquired immunodeficiency syndrome.

Authors:  D L Bowen; H C Lane; A S Fauci
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

3.  Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS).

Authors:  G Sunderam; R J McDonald; T Maniatis; J Oleske; R Kapila; L B Reichman
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

4.  Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis.

Authors:  B Damsker; E J Bottone
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

5.  The seroagglutination test in the study of nontuberculous mycobacteria.

Authors:  J K McClatchy
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

6.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

7.  Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare.

Authors:  P R Gangadharam; C K Edwards
Journal:  Am Rev Respir Dis       Date:  1984-11

8.  Thin-layer chromatography of lipid antigens as a means of identifying nontuberculous mycobacteria.

Authors:  P J Brennan; M Heifets; B P Ullom
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

9.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.

Authors:  C C Hawkins; J W Gold; E Whimbey; T E Kiehn; P Brannon; R Cammarata; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

  9 in total
  27 in total

1.  Characterization of isolates of Mycobacterium avium serotypes 4 and 8 from patients with AIDS by multilocus enzyme electrophoresis.

Authors:  M A Yakrus; M W Reeves; S B Hunter
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.

Authors:  M Picardeau; A Varnerot; T Lecompte; F Brel; T May; V Vincent
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 4.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

5.  Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.

Authors:  D M Yajko; J Kirihara; C Sanders; P Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

6.  Serovars of Mycobacterium avium complex isolated from patients in Denmark.

Authors:  D S Askgaard; S B Giese; S Thybo; A Lerche; J Bennedsen
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

7.  Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome.

Authors:  M A Yakrus; R C Good
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Mycobacterium avium glycopeptidolipids require specific acetylation and methylation patterns for signaling through toll-like receptor 2.

Authors:  Lindsay Sweet; Wenhui Zhang; Heidi Torres-Fewell; Anthony Serianni; William Boggess; Jeffrey Schorey
Journal:  J Biol Chem       Date:  2008-09-29       Impact factor: 5.157

9.  Indomethacin-sensitive monocyte killing defect in a child with disseminated atypical mycobacterial disease.

Authors:  D Ridgway; L J Wolff; M Wall; M S Borzy; C H Kirkpatrick
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

Review 10.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.